Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs UMAC✓SelectedUSD · UMACGSK vs UMAC performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs UMAC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1.7%
UMAC return
-25.4%
Excess return
+27.1%
Maximum drawdown
-13.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioUMACExcessAlpha
1D+0.5%-4.6%+5.2%+0.4%
7D+1.1%-5.2%+6.4%+1.1%
30D+6.3%-36.4%+42.7%+5.3%
3M+1.8%-58.6%+60.4%+0.1%
6M+1.7%-24.6%+26.3%+1.0%
All+1.7%-25.4%+27.1%+1.0%

Cumulative growth

Daily Returns

Daily percentage return beside UMAC.

Daily Out/Under-Performance

Portfolio return minus UMAC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × UMAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded UMAC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling